Inventor · disambiguated record
Bryan A. Frieman
Also filed as: FRIEMAN BRYAN · FRIEMAN BRYAN A
27 granted patents·16 pending applications·194 citations·filing 2008–2024
96Inventor score
Top patents by PatentIndex Score
43 records- 0197US11591350B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Feb 28, 2023·7 cites·27 claims
- 0297US11584761B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Feb 21, 2023·9 cites·37 claims
- 0397US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 0497US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 0597US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 0696US11873300B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Jan 16, 2024·6 cites·25 claims
- 0796US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 0896US10570115B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Feb 25, 2020·23 cites·18 claims
- 0995US12421251B2Cystic fibrosis transmembrane conductance regulator modulating agentsVERTEX PHARMA·Filed 2020·Granted Sep 23, 2025·5 cites·25 claims
- 1095US11066417B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2019·Granted Jul 20, 2021·13 cites·47 claims
- 1194US11866450B2Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·3 cites·41 claims
- 1293US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
- 1393US12122788B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Oct 22, 2024·1 cites·21 claims
- 1492US11186566B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Nov 30, 2021·10 cites·10 claims
- 1592US7902220B28-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonistsTHERAVANCE INC·Filed 2008·Granted Mar 8, 2011·14 cites·14 claims
- 1691US10738030B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Aug 11, 2020·6 cites·48 claims
- 1788US2025205232A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1886US8481563B28-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonistsSAITO DAISUKE ROLAND·Filed 2011·Granted Jul 9, 2013·7 cites·19 claims
- 1985US12319693B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 2081US8598164B2Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2011·Granted Dec 3, 2013·5 cites·68 claims
- 2178US2024368189A1Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the ModulatorsVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2271US2022306606A1Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2364US9199993B28-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonistsSAITO DAISUKE ROLAND·Filed 2014·Granted Dec 1, 2015·0 cites·12 claims
- 2462US8802698B28-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonistsSAITO DAISUKE ROLAND·Filed 2013·Granted Aug 12, 2014·0 cites·6 claims
- 2556US2023382924A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2656US2023416275A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2756US2023373974A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2856US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2956US2023373939A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3056US2023373935A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3156US2023365587A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3256US2024018161A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3356US2023374038A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3456US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3555US9181273B2Morpholine-spirocyclic piperidine amides as modulators of ion channelsVERTEX PHARMA·Filed 2014·Granted Nov 10, 2015·0 cites·21 claims
- 3653US2022047564A1Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 3751US2014171427A1Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2013·Application pending·0 cites
- 3850US2022313698A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 3949US8828996B2Morpholine-spirocyclic piperidine amides as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2012·Granted Sep 9, 2014·0 cites·79 claims
- 4046US10233191B2Fused piperidine amides as modulators of ion channelsVERTEX PHARMA·Filed 2014·Granted Mar 19, 2019·0 cites·32 claims
- 4142US9403839B2Pyran-spirocyclic piperidine amides as modulators of ion channelsVERTEX PHARMA·Filed 2013·Granted Aug 2, 2016·0 cites·23 claims
- 4241US10385070B2Chroman-spirocyclic piperidine amides as modulators of ion channelsHADIDA RUAH SARA SABINA·Filed 2012·Granted Aug 20, 2019·0 cites·43 claims
- 4341US9365588B2Benzoxazines as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2012·Granted Jun 14, 2016·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Bryan A. Frieman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →